SEC 13F Intelligence

Trv GP Vi, LLC / RAPP

Trv GP Vi, LLC’s Rapport Therapeutics Inc Position

Does Trv GP Vi, LLC own Rapport Therapeutics Inc (RAPP)? Yes — 969.2K shares worth $30M (+22.37% of its 13F portfolio) as of Q1 2026.

Position Value
$30M
Q1 2026
Shares
969.2K
% of Portfolio
+22.37%
Quarters Held
6
currently held

Position History RAPP

Reported value by quarter
Q4 ’24: $17MQ4 ’24Q1 ’25: $10MQ1 ’25Q2 ’25: $11MQ2 ’25Q3 ’25: $29MQ3 ’25Q4 ’25: $29MQ4 ’25Q1 ’26: $30MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026969.2K$30M+22.37%
Q4 2025969.2K$29M+19.80%
Q3 2025969.2K$29M+26.26%
Q2 2025969.2K$11M+17.16%
Q1 2025969.2K$10M+23.16%
Q4 2024969.2K$17M+14.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trv GP Vi, LLC’s full portfolio or all institutional holders of RAPP.